English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 148 Help

Selected(0)Clear Items/Page:    Sort:
The role of hospital pharmacists in supporting the appropriate and safe use of CGT/ATMPs: a scoping review of current insights Journal article
Shi, Junnan, Chen, Xianwen, Hu, Hao, Ung, Carolina Oi Lam. The role of hospital pharmacists in supporting the appropriate and safe use of CGT/ATMPs: a scoping review of current insights[J]. BMC health services research, 2025, 25(1), 52.
Authors:  Shi, Junnan;  Chen, Xianwen;  Hu, Hao;  Ung, Carolina Oi Lam
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.7/3.1 | Submit date：2025/01/22
Advanced Therapy Medicinal Products  Cell And Gene Therapy  Hospital Pharmacy  Pharmaceutical Care  Pharmacy Practice  Regeneration Medicine  
Using system dynamics modeling approach to strengthen health systems to combat cancer: a systematic literature review Journal article
Chen, Xianwen, Cai, Kuangyuan, Xue, Yan, Ung, Carolina Oi Lam, Hu, Hao, Jakovljevic, Mihajlo. Using system dynamics modeling approach to strengthen health systems to combat cancer: a systematic literature review[J]. Journal of Medical Economics, 2025, 28(1), 168-185.
Authors:  Chen, Xianwen;  Cai, Kuangyuan;  Xue, Yan;  Ung, Carolina Oi Lam;  Hu, Hao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.9/2.9 | Submit date：2025/01/22
Cancer Control  Cancer Diagnosis  Cancer Screening  Cancer Treatment  System Dynamics Modeling  
Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma Journal article
Zou, Huimin, Lai, Yunfeng, Chen, Xianwen, Ung, Carolina Oi Lam, Hu, Hao. Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma[J]. Therapeutic Advances in Gastroenterology, 2025, 18, 1-13.
Authors:  Zou, Huimin;  Lai, Yunfeng;  Chen, Xianwen;  Ung, Carolina Oi Lam;  Hu, Hao
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.9/4.0 | Submit date：2025/01/22
Camrelizumab  Cost-effectiveness Analysis  Hepatocellular Carcinoma  Partitioned Survival Model  Rivoceranib  
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study Journal article
Hu, Ying, Chen, Xianwen, Zou, Huimin, Zhang, Hao, Ni, Qi, Li, Yijun, Ung, Carolina Oi Lam, Hu, Hao, Mu, Yiming. Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study[J]. Advances in Therapy, 2024.
Authors:  Hu, Ying;  Chen, Xianwen;  Zou, Huimin;  Zhang, Hao;  Ni, Qi; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.4/4.0 | Submit date：2024/12/26
China  Modeling  Semaglutide  Type 2 Diabetes Mellitus  
The Role of Hospital Pharmacists in Supporting the Appropriate and Safe Use of CGT/ATMPs: A Scoping Review of Current Insights Journal article
UNG OI LAM CAROLINA. The Role of Hospital Pharmacists in Supporting the Appropriate and Safe Use of CGT/ATMPs: A Scoping Review of Current Insights[J]. BMC Health Services Research, 2024.
Authors:  UNG OI LAM CAROLINA
Adobe PDF | Favorite |   IF:2.7/3.1 | Submit date：2024/12/26
Challenges and strategies of developing internet hospital: Combining qualitative interview and documentary research Journal article
Lai, Yunfeng, Ho, Qiong, Wang, Yao, Liang, Xiaonan, Xue, Yan, Ung, Carolina Oi Lam, Li, Meng, Yao, Dongning, Liu, Buping, Bian, Ying, Xie, Zhirong, Hu, Hao. Challenges and strategies of developing internet hospital: Combining qualitative interview and documentary research[J]. Digital Health, 2024, 10, 20552076241310075.
Authors:  Lai, Yunfeng;  Ho, Qiong;  Wang, Yao;  Liang, Xiaonan;  Xue, Yan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.9/3.7 | Submit date：2025/01/13
Internet Hospital  Development Challenge  Development Strategy  Service Model  China  
Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China Journal article
Ruan, Zhen, Chen, Xianwen, Song, Menghuan, Jia, Ruxu, Luo, Hang, Ung, Carolina Oi Lam, Hu, Hao. Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China[J]. Diabetes, Metabolic Syndrome and Obesity, 2024, 17, 3657-3666.
Authors:  Ruan, Zhen;  Chen, Xianwen;  Song, Menghuan;  Jia, Ruxu;  Luo, Hang; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:2.8/3.3 | Submit date：2024/11/05
Type 2 Diabetes Mellitus  Glucagon-like Peptide-1 Receptor Agonist  Glp-1ra  Retrospective  China  Electronic Medical Record  Real-world  
Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: a systematic review and meta-analysis Journal article
Lei, Pek Kei, Liu, Zicheng, Ung, Carolina Oi Lam, Hu, Hao. Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: a systematic review and meta-analysis[J]. BMC gastroenterology, 2024, 24(1), 331.
Authors:  Lei, Pek Kei;  Liu, Zicheng;  Ung, Carolina Oi Lam;  Hu, Hao
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.5/2.7 | Submit date：2024/10/10
Clinical Trial  Direct-acting Antiviral  Hepatitis c Virus  Meta-analysis  
Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis Journal article
Ying Liu, Ella Man-Wai Un, Ying Bai, Man Keong Chan, Luo Xin Zeng, Sut Leng Lei, Junjun Li, UNG OI LAM CAROLINA. Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis[J]. Journal of Pharmacy & Pharmaceutical Sciences, 2024, 27, 13206.
Authors:  Ying Liu;  Ella Man-Wai Un;  Ying Bai;  Man Keong Chan;  Luo Xin Zeng; et al.
Adobe PDF | Favorite | TC[WOS]:1 TC[Scopus]:1  IF:2.9/2.6 | Submit date：2024/08/27
Fetal Growth Restriction  Intrauterine Growth Restriction  Phosphodiesterase-5 Inhibitors  Sildenafil  Tadalafil  
The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards Journal article
Shi, Junnan, Chen, Xianwen, Hu, Hao, Ung, Carolina Oi Lam. The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards[J]. Cytotherapy, 2024, 26(8), 954-966.
Authors:  Shi, Junnan;  Chen, Xianwen;  Hu, Hao;  Ung, Carolina Oi Lam
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.7/4.3 | Submit date：2024/06/05
Advanced Therapy Medicinal Products  China  Drug Regulatory Authority  Global Benchmarking Tool (Gbt)  Regulatory Science